Drug eluting stents can release locally pharmaceutical active ingredients, particularly in the ureter and bladder, increasing the bioavailability and efficacy of the drugs. Although drug eluting stents has been widely used and commercially available in other fields, such as cardiology, its role in urology is limited. In his work, we propose the production of biodegradable stents using a simple technology, developed and patented by the team as drug new drug delivery devices, namely for the delivery of anti-cancer drugs for the treatment of upper urinary tract urothelial carcinoma.
